Science News
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot